These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6754101)

  • 21. The role of immunoglobulin receptors on lymphocytes in production of MIF in guinea pigs.
    GoĊ›cicka T
    Cell Immunol; 1974 Aug; 13(2):207-15. PubMed ID: 4141646
    [No Abstract]   [Full Text] [Related]  

  • 22. MIF production of lymphocytes from patients with rheumatoid arthritis with antigen-antibody complexes.
    Eibl MM; Sitko C
    Ann Rheum Dis; 1975 Apr; 34(2):117-21. PubMed ID: 1094964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of an antibody against guinea pig MIF. II. Analysis of the antibody-reacting material using radiolabeled lymphokines.
    Onozaki K; Haga S; Miura K; Homma Y; Hashimoto T
    Cell Immunol; 1980 Oct; 55(2):465-75. PubMed ID: 7000379
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.
    Leu RW; Eddleston AL; Hadden JW; Good RA
    J Exp Med; 1972 Sep; 136(3):589-603. PubMed ID: 4115133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid method for measuring the production of human migration inhibitory factor (MIF).
    Lipsmeyer EA
    Cell Immunol; 1974 Jun; 12(3):481-6. PubMed ID: 4617635
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulatory mechanisms of cutaneous delayed-type hypersensitivity. I. Suppression of cutaneous delayed-type hypersensitivity by migration inhibitory factor.
    Mizushima A; Baba T; Ochiya T; Yamaguchi K; Onozaki K; Yaoita H; Uyeno K
    Cell Immunol; 1983 Oct; 81(1):126-33. PubMed ID: 6352055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode Strongyloides acting at the parasite-host cell interface.
    Younis AE; Soblik H; Ajonina-Ekoti I; Erttmann KD; Luersen K; Liebau E; Brattig NW
    Microbes Infect; 2012 Mar; 14(3):279-89. PubMed ID: 22037391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of an antibody against guinea pig MIF. III. Biological activity of MIF recovered from immunoadsorbent column chromatography.
    Onozaki K; Haga S; Ichikawa M; Homma Y; Miura K; Hashimoto T
    Cell Immunol; 1981 Jun; 61(1):165-75. PubMed ID: 7020954
    [No Abstract]   [Full Text] [Related]  

  • 30. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of macrophages in incontinentia pigmenti histologica. Migration and phagocytosis of macrophages.
    Takematsu H; Seiji M
    J Dermatol; 1980 Oct; 7(5):335-9. PubMed ID: 7009683
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of MIF by a factor in human serum.
    Ward PA; Rocklin RE
    J Immunol; 1975 Jul; 115(1):309-11. PubMed ID: 50355
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional activation of immune lymphocytes by antigenic stimulation in cell mediated immunity. I. Requirement for macrophages in antigen-induced MIF production by guinea pig immune lymphocytes in vitro.
    Ohishi M; Onoue K
    Cell Immunol; 1975 Jul; 18(1):220-32. PubMed ID: 806355
    [No Abstract]   [Full Text] [Related]  

  • 35. Identity of specific macrophage-active human lymphokines.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    Lancet; 1978 Apr; 1(8066):718-9. PubMed ID: 76257
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of cellular immune function in vitro by histamine receptor-bearing lymphocytes: mechanism of action.
    Rocklin RE; Greineder D; Littman BH; Melmon KL
    Cell Immunol; 1978 Apr; 37(1):162-73. PubMed ID: 350418
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of macrophage migration by normal guinea pig intestinal secretions.
    Gadol N; Waldman RH; Clem LW
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):654-8. PubMed ID: 772687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of heparin on chemotactic and migration inhibitory lymphokines.
    Yoshida T; Amsden A; Ksiazek J; Cohen S
    Clin Immunol Immunopathol; 1978 Jul; 10(3):287-91. PubMed ID: 352595
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).
    Kim S; Miska KB; Jenkins MC; Fetterer RH; Cox CM; Stuard LH; Dalloul RA
    Dev Comp Immunol; 2010 Sep; 34(9):1021-32. PubMed ID: 20470818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.